4,430
Participants
Start Date
March 5, 2015
Primary Completion Date
September 30, 2022
Study Completion Date
September 30, 2022
Tacrolimus
oral
Site TW8861, Tainan City
Site HU3602, Budapest
Site PH6303, Quezon City
Site NL3104, Amsterdam
Site AU6107, Camperdown
Site AU6103, Westmead
Site AU6106, Gosford
Site AU6104, New Lambton
Site BE3201, Leuven
Site NL3101, Utrecht
Site AT4304, Linz
Site HU3601, Debrecen
Site AU6111, Harvey Bay
Site AU6108, North Adelaide
Site AU6110, Nedlands
Site AT4302, Innsbruck
Site AT4303, Innsbruck
Site AU6105, Perth
Site NL3103, Nijmegen
Site AT4301, Graz
Site KR8213, Seoul
Site NL3105, Groningen
Site VN8401, Hà Nội
Site TH6601, Bangkok
Site TH6602, Bangkok
Site GR3002, Athens
Site SB3801, Belgrade
Site SB3802, Belgrade
Site GR3004, Athens
Site FR3315, Marseille
Site FR3303, Caen
Site KR8216, Bucheon-si
Site ES3410, Santiago de Compostela
Site IT3901, Genova
Site KR8218, Suwon
Site SB3804, Niš
Site SB3803, Novi Sad
Site KR8201, Incheon
Site FR3306, Besançon
Site IT3911, Novara
Site IT3916, Novara
Site FR3311, Brest
Site IT3906, Venezia
Site DE4903, Hanover
Site FR3313, Toulouse
Site FR3302, Bordeaux
Site IT3915, Udine
Site FR3317, Rennes
Site IT3910, Padua
Site FR3305, Tours
Site IT3907, Verona
Site IT3914, Bolzano
Site TH6603, Khon Kaen
Site IT3902, Bologna
Site TW8863, Taichung
Site KR8219, Daegu
Site FR3309, Saint-Étienne-de-Montluc
Site KR8215, Ulsan
Site KR8214, Busan
Site FR3314, Angers
Site FR3325, Lille
Site MY6001, Kuala Lumpur
Site KR8212, Gwangju
Site FR3319, Clermont-Ferrand
Site FR3318, Strasbourg
Site IT3904, L’Aquila
Site DE4902, Mannheim
Site FR3324, Lyon
Site VN8402, Ho Chi Minh City
Site IT3905, Bari
Site FR3323, Paris
Site FR3307, Rouen
Site FR3308, Amiens
Site IT3903, Napoli
Site TW8862, Kaohsiung City
Site IT3912, Salerno
Site IT39013, Salerno
Site IT3913, Salerno
Site FR3322, Poitiers
Site FR3321, Limoges
Site FR3301, Créteil
Site FR3316, Le Kremlin-Bicêtre
Site DE4901, Würzburg
Site RO4004, Cluj-Napoca
Site CA1001, Vancouver
Site CZ4202, Olomouc
Site FR3310, Nice
Site FR3312, Nantes
Site HK8201, Hong Kong
Site HK8521, Hong Kong
Site JP8108, Nagoya
Site JP8109, Toyoake
Site JP8107, Chiba
Site JP8110, Nishinomiya
Site JP8111, Nishinomiya
Site JP8106, Kawasaki-shi
Site JP8105, Ōta-ku
Site JP8104, Shinjuku-Ku
Site JP8101, Akita
Site JP8102, Niigata
Site IT3909, Perugia
Site IT3908, Sassari
Site PL4806, Poznan
Site PL4808, Lublin
Site PL4801, Warsaw
Site PL4807, Szczecin
Site PT3511, Porto
Site RO4001, Bucharest
Site RO4002, Bucharest
Site RO4003, Bucharest
Site KR8205, Busan
Site KR8203, Pusan
Site KR8202, Daegu
Site KR8207, Daejeon
Site KR8211, Seoul
Site KR8210, Seoul
Site KR8206, Seoul
Site KR8209, Seoul
Site KR8204, Seoul
Site KR8208, Seoul
Site ES3401, Barcelona
Site ES3403, Barcelona
Site GB4403, Peterborough
Site GB4405, Exeter
Site GB4406, Manchester
Site GB4407, Ipswich
Site GB4401, Leeds
Site GB4402, Liverpool
Site GB4408, London
Astellas Pharma Europe Ltd.
INDUSTRY